In contrast to these findings, some have observed that in different types of human cancer (e.g., breast, lung, hepatocellular and prostate carcinomas), dyskerin expression and pseudouridylation levels are frequently higher, and are associated with poor patient prognosis, malignant progression, and lower disease-free survival [218,219,220]. This evidence concerns the gene DKC1 and prostate carcinoma.